Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1996 3
1998 3
1999 8
2000 6
2001 3
2002 2
2003 2
2004 2
2005 2
2006 2
2007 2
2009 2
2010 3
2012 2
2013 1
2015 2
2016 1
2017 1
2018 4
2020 3
2021 5
2022 3
2023 5
2024 9
2025 12
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
Foà R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo MC, Canichella M, Viero P, Ferrara F, Lunghi M, Fabbiano F, Bonifacio M, Fracchiolla N, Di Bartolomeo P, Mancino A, De Propris MS, Vignetti M, Guarini A, Rambaldi A, Chiaretti S; GIMEMA Investigators. Foà R, et al. N Engl J Med. 2020 Oct 22;383(17):1613-1623. doi: 10.1056/NEJMoa2016272. N Engl J Med. 2020. PMID: 33085860 Clinical Trial.
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.
Bassan R, Chiaretti S, Della Starza I, Santoro A, Spinelli O, Tosi M, Elia L, Cardinali D, De Propris MS, Piccini M, Lussana F, Annunziata M, Chiusolo P, Zappasodi P, Borlenghi E, Leoncin M, Califano C, Bocchia M, Di Raimondo F, Grimaldi F, Tiribelli M, Candoni A, Lico A, Audisio E, Lunghi M, Mianulli AM, Di Trani M, Arena V, Messina M, Piciocchi A, Fazi P, Rambaldi A, Foà R. Bassan R, et al. Among authors: califano c. Blood. 2025 May 22;145(21):2447-2459. doi: 10.1182/blood.2024027500. Blood. 2025. PMID: 40009490 Clinical Trial.
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
De Novellis D, Derudas D, Vincelli D, Fontana R, Della Pepa R, Palmieri S, Accardi F, Rotondo F, Morelli E, Gigliotta E, Roccotelli D, Marano L, Barone ML, Cetani G, Esposito D, Lazzaro A, Delle Cave G, Serio B, Morini D, Porrazzo M, Urciuoli E, Masucci C, Fanelli F, Rizzo M, Arcamone M, Trastulli F, Rocco S, Leone A, Bianco R, Salvatore F, Idato A, Sicari M, Tosi P, Rascato MG, Di Perna M, Falcone AP, Morello L, Carlisi M, Svanera G, Annunziata M, Frigeri F, Califano C, Carella AM, Marcacci G, Pane F, Risitano AM, Giudice V, Botta C, Selleri C. De Novellis D, et al. Among authors: califano c. Eur J Haematol. 2025 Jan;114(1):105-114. doi: 10.1111/ejh.14314. Epub 2024 Oct 6. Eur J Haematol. 2025. PMID: 39370303 Free PMC article.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Lanino L, Restuccia F, Perego A, Ubezio M, Fattizzo B, Riva M, Consagra A, Musto P, Cilloni D, Oliva EN, Palmieri R, Poloni A, Califano C, Capodanno I, Itri F, Elena C, Fozza C, Pane F, Pelizzari AM, Breccia M, Di Bassiano F, Crisà E, Ferrero D, Giai V, Barraco D, Vaccarino A, Griguolo D, Minetto P, Quintini M, Paolini S, Sanpaolo G, Sessa M, Bocchia M, Di Renzo N, Diral E, Leuzzi L, Genua A, Guarini A, Molteni A, Nicolino B, Occhini U, Rivoli G, Bono R, Calvisi A, Castelli A, Di Bona E, Di Veroli A, Ferrara F, Fianchi L, Galimberti S, Grimaldi D, Marchetti M, Norata M, Frigeni M, Sancetta R, Selleri C, Tanasi I, Tosi P, Turrini M, Giordano L, Finelli C, Pasini P, Naldi I, Santini V, Della Porta MG; Fondazione Italiana Sindromi Mielodisplastiche (FISiM) Clinical network (https://www.fisimematologia.it/). Lanino L, et al. Among authors: califano c. Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24. Am J Hematol. 2023. PMID: 37222267 Free article. No abstract available.
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Martorelli MC, Pugliese N, Di Perna M, De Novellis D, Lombardi A, De Fazio L, Loglisci G, Peluso I, Molica M, Copia C, Ricco A, Bruzzese A, Mendicino F, De Fazio V, Santeramo TM, Bianco R, Monaco G, Fontana R, Guariglia R, Serio B, Luponio S, Della Corte AM, Malandrini A, Giudice V, Frigeri F, Tarantini G, Guarini A, Gentile M, Musto P, Annunziata M, Di Renzo N, Rossi M, Califano C, Pane F, Selleri C. Martorelli MC, et al. Among authors: califano c. Eur J Haematol. 2026 Jan;116(1):23-30. doi: 10.1111/ejh.70034. Epub 2025 Sep 16. Eur J Haematol. 2026. PMID: 40955124 Free PMC article.
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.
Morabito F, Martino EA, Galli M, Offidani M, Zambello R, Bringhen S, Giuliani N, Califano C, Brunori M, Gagliardi A, Sgherza N, Quinto AM, Barilà G, Belotti A, Cerchione C, Casaluci GM, Fontana R, Bongarzoni V, Tarantini G, Derudas D, Patriarca F, Gozzetti A, Sementa A, Antonioli E, Rago A, Lotti F, De Magistris C, Petrucci MT, Pettine L, Bolli N, Conticello C, Zamagni E, Palmieri S, Musso M, Mele A, Della Pepa R, Vigna E, Bruzzese A, Fazio F, Mina R, Paris L, Vincelli ID, Farina G, Cangialosi C, Mancuso K, Falcone AP, Mele G, Sica A, Morè S, Reddiconto G, Tripepi G, D'Arrigo G, Barbieri E, Quaresima M, Cartia CS, Pezzatti S, Marcatti M, Farina F, Cafro A, Palumbo M, Masoni V, Ferretti VV, Di Raimondo F, Musto P, Neri A, Mangiacavalli S, Gentile M. Morabito F, et al. Among authors: califano c. Eur J Haematol. 2025 Jul;115(1):16-28. doi: 10.1111/ejh.14413. Epub 2025 Mar 19. Eur J Haematol. 2025. PMID: 40103518 Free PMC article.
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.
Martino EA, Pitino A, Offidani M, Della Pepa R, Gozzetti A, Bongarzoni V, Maroccia A, Amico V, Stefanoni P, Zamagni E, Terlizzi S, Derudas D, Palmieri S, Bianco R, Conticello C, Brunori M, Rago A, Lotti F, Fontana R, Sgherza N, Rossi E, Cafro AM, Febbo MA, Quinto AM, Cerchione C, Casaluci GM, Citro A, Califano C, Zambello R, Mangiacavalli S, Liberatore C, Buda G, De Magistris C, Amendola A, Vigna E, Bruzzese A, Barbieri E, Quaresima M, Roccotelli D, Farina F, Micozzi J, Vincelli ID, Tarantini G, Antonioli E, Aquino S, Maggi A, Lombardo A, Bertuglia G, Furlan A, Mele A, Annibali O, Cotzia E, Benvenuti P, De Paoli L, Barilà G, Morè S, De Stefano V, Di Raimondo F, Petrucci MT, Bolli N, Musto P, Neri A, Morabito F, Tripepi G, Gentile M. Martino EA, et al. Among authors: califano c. Haematologica. 2025 Mar 6;110(8):1875-1881. doi: 10.3324/haematol.2025.287325. Haematologica. 2025. PMID: 40761134 Free PMC article. No abstract available.
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
Martino EA, Derudas D, Rossi E, Terlizzi S, Reddiconto G, Stefanoni P, Micozzi J, Mangiacavalli S, Zamagni E, Offidani M, Furlan A, Buda G, Lotti F, Liberatore C, Lazzaro A, Della Pepa R, Bertuglia G, Barbieri E, Conticello C, De Magistris C, De Paoli L, Bongarzoni V, Cafro AM, Mele A, Benvenuti P, Cerchione C, Botta C, Antonioli E, Sgherza N, Aquino S, Mele G, Barilà G, Palmieri S, Annibali O, Bianco R, Febbo MA, Casaluci GM, Rago A, Fontana R, Farina F, Vigna E, Bruzzese A, Mancuso K, Nappi D, Morè S, Rivolti E, Califano C, Amendola A, Roccotelli D, Lombardo A, Citro A, Uccello G, Zambello R, Maggi A, Neri S, Monachesi M, Gozzetti A, Montefusco V, Brunori M, Cotzia E, Pietrantuono G, Quinto AM, Amico V, Di Renzo N, Coscia M, Galli M, De Stefano V, Petrucci MT, Neri A, Di Raimondo F, Morabito F, Musto P, Gentile M. Martino EA, et al. Among authors: califano c. Haematologica. 2025 Apr 1;110(4):1028-1033. doi: 10.3324/haematol.2024.286658. Epub 2024 Nov 28. Haematologica. 2025. PMID: 39605207 Free PMC article. No abstract available.
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Guerra L, Chauvie S, Fallanca F, Bergesio F, Marcheselli L, Durmo R, Peano S, Franceschetto A, Monaco L, Barbieri E, Ladetto M, Musuraca G, Tosi P, Bianchi B, Bolis SAM, Pavone V, Chiarenza A, Arcari A, Califano C, Bari A, Massaia M, Conconi A, Musto P, Mannina D, Roti G, Galimberti S, Gini G, Falcinelli F, Vitolo U, Usai SV, Stefani PM, Ibatici A, Liberati AM, Pennese E, Perrone T, Versari A, Luminari S; Fondazione Italiana Linfomi (FIL). Guerra L, et al. Among authors: califano c. Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 May 25. Eur J Nucl Med Mol Imaging. 2024. PMID: 38795120 Clinical Trial.
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial.
Benevolo G, Drandi D, Villivà N, Castiglione A, Monaco F, Boccomini C, Dessi D, Califano C, Curreli L, Cavallo F, Conconi A, Gaidano G, Rossi FG, Caravita di Toritto T, Ferrante M, Mannina D, Tosi P, Pietrantuono G, Musuraca G, Merli M, Sartori R, Tani M, Freilone R, Varettoni M, Ferrero S. Benevolo G, et al. Among authors: califano c. Br J Haematol. 2025 Feb;206(2):556-564. doi: 10.1111/bjh.19920. Epub 2024 Nov 27. Br J Haematol. 2025. PMID: 39604169 Clinical Trial.
82 results